Brief: Frequency Therapeutics Inc - Qtrly Loss Per Share $0.67
May 4 (Reuters) - Frequency Therapeutics Inc FREQ.O :
* FREQUENCY THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.67
* FREQUENCY THERAPEUTICS - BELIEVES EXISTING CASH,
EQUIVALENTS AND
MARKETABLE SECURITIES WILL BE SUFFICIENT TO FUND ITS OPERATIONS
INTO 2024
* FREQUENCY THERAPEUTICS INC - CASH, CASH EQUIVALENTS AND
MARKETABLE SECURITIES AS OF MARCH 31, 2022, WERE $124.8 MILLION
(EXCLUDING RESTRICTED CASH)
Source text for Eikon: ID:nBw5fKRXJa
Further company coverage: FREQ.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Korro Bio
See all newsBrief: Korro Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Korro Announces First Cohort Dosed In Phase 1/2 Clinical Trial (Anchor) For Krro-121
Brief: Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Korro Bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Korro Bio, Inc. expected to post a loss of $1.43 a share - Earnings Preview